Navigation Links
Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Date:12/17/2008

ST. PAUL, Minn., Dec. 17 /PRNewswire/ -- Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM) company, announced today that Steven Blumenfield has joined the organization as Chief Marketing Officer (CMO).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081217/AQW507)

As CMO, Mr. Blumenfield has overall responsibility for Prime's marketing strategy, product development and other market-related initiatives. He will focus on continuing Prime's expansion and in helping to enhance the value that Prime delivers to its Blue Cross and Blue Shield clients and employer groups.

"In an effort to better position ourselves as an industry leading PBM, Prime has hired Steve Blumenfield as Chief Marketing Officer," said Tim Dickman, President and CEO of Prime Therapeutics. "Steve will be a great asset for enhancing strategic partnerships with our clients. With a health care and marketing background that spans 20 years, Steve understands health care, the pharmacy space, and Prime's clients and members. He will help us to partner in ways that will enhance our go-to-market capabilities."

Mr. Blumenfield was most recently a Health and Welfare Practice Leader and Principal at Towers Perrin. Prior to that role, he was responsible for pharmacy intellectual capital and the firm's pharmaceuticals sector. He received his bachelor's degree in Marketing from Rutgers University and his MBA from the University of Chicago's Graduate School of Business in Behavioral Decision Making and Business Policy.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and thirdparty administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Lab Series(R) Skincare For Men Spa Indulges the 2007 Primetime Emmy(R) Nominees at the Sofitel(R) Los Angeles
3. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
4. Prime Therapeutics Announces URAC Accreditation
5. Prime Minister views innovative health technology at Imperial College London
6. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
7. Prime Healthcare Services Acquires Centinela Hospital Medical Center
8. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
9. Announcing Prime Vendor Contract with LIHPA
10. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
11. Fetal Alcohol Exposure May Prime Offspring for Alcoholism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Boar’s Head ... just in time for this weekend’s Big Game. Take the stress out of your ... will keep your guests happy at every stage of the game. , “The key ...
(Date:2/5/2016)... ... 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled to ... the most effective tattoo removal today, Dr. Bentkover is the only doctor in Central ... the PicoSure has been approved by the Food and Drug Administration (FDA) as a ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that ... the event they are experiencing an illness. Migraines are a severe form of a ... with migraines would not wish the pain on their worst enemy, the feeling can ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 5, 2016 --> ... report "Fetal (Labor & Delivery) and Neonatal Care Equipment ... Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) ... report studies the global market over the forecast period ... USD 6.28 Billion in 2015 and is poised to ...
(Date:2/4/2016)... For hospitals considering enrollment in the Federal ... the program, the Health Resources and Services Administration,s (HRSA) ... Mega-Guidance , could have significant impact on plans and ... 2016. Essential Insights , Daniel Neal, ... the Mega-Guidance,s key proposed changes, including a new requirement ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
Breaking Medicine Technology: